BE831042A - Compositions pharmaceutiques a resorption per-cutanee contenant des alcools aliphatiques superieurs et des agents tensio-actifs - Google Patents
Compositions pharmaceutiques a resorption per-cutanee contenant des alcools aliphatiques superieurs et des agents tensio-actifsInfo
- Publication number
- BE831042A BE831042A BE158022A BE158022A BE831042A BE 831042 A BE831042 A BE 831042A BE 158022 A BE158022 A BE 158022A BE 158022 A BE158022 A BE 158022A BE 831042 A BE831042 A BE 831042A
- Authority
- BE
- Belgium
- Prior art keywords
- per
- pharmaceutical compositions
- active agents
- compositions containing
- aliphatic alcohols
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH931274 | 1974-07-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
BE831042A true BE831042A (fr) | 1976-01-05 |
Family
ID=4350618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE158022A BE831042A (fr) | 1974-07-05 | 1975-07-04 | Compositions pharmaceutiques a resorption per-cutanee contenant des alcools aliphatiques superieurs et des agents tensio-actifs |
Country Status (14)
Country | Link |
---|---|
JP (1) | JPS5132724A (hu) |
AU (1) | AU8280175A (hu) |
BE (1) | BE831042A (hu) |
DE (1) | DE2528516A1 (hu) |
ES (1) | ES439113A1 (hu) |
FR (1) | FR2276832A1 (hu) |
GB (1) | GB1518683A (hu) |
HU (1) | HU170215B (hu) |
IL (1) | IL47634A (hu) |
NL (1) | NL7507798A (hu) |
NZ (1) | NZ178011A (hu) |
SE (1) | SE7507414L (hu) |
YU (1) | YU170475A (hu) |
ZA (1) | ZA754304B (hu) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54163810A (en) * | 1978-06-14 | 1979-12-26 | Mundipharma Ag | Gel composition for local coating |
JPS56159310A (en) * | 1980-05-14 | 1981-12-08 | Showa Denko Kk | Preparation of monofilament having high strength and knot strength |
FR2483235A1 (fr) * | 1980-05-28 | 1981-12-04 | Fabre Sa Pierre | Compositions a usage topique contenant des alcaloides de l'ergot de seigle et de vinca rosea destinees au traitement des hyperseborrhees |
JPS59216825A (ja) * | 1983-05-23 | 1984-12-06 | Takeda Chem Ind Ltd | 経皮吸収外用製剤 |
US5128376A (en) * | 1983-07-01 | 1992-07-07 | Nitto Denko Corporation | Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator |
US4590190A (en) * | 1983-07-01 | 1986-05-20 | Nitto Electric Industrial Co., Ltd. | Method for percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent |
US4752612A (en) * | 1983-07-01 | 1988-06-21 | Nitto Electrical Industrial Co., Ltd. | Method and percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent |
JPS6013720A (ja) * | 1983-07-01 | 1985-01-24 | Nitto Electric Ind Co Ltd | 生理的活性剤の吸収促進剤 |
US4751087A (en) * | 1985-04-19 | 1988-06-14 | Riker Laboratories, Inc. | Transdermal nitroglycerin delivery system |
JPH0735331B2 (ja) * | 1986-01-16 | 1995-04-19 | 久光製薬株式会社 | 外用ゲル製剤 |
JPH0735332B2 (ja) * | 1986-02-25 | 1995-04-19 | 久光製薬株式会社 | 外用クリ−ム製剤 |
JPH0759519B2 (ja) * | 1987-02-23 | 1995-06-28 | 株式会社資生堂 | 経皮吸収促進剤及びこれを含有する皮膚外用製剤 |
US4746515A (en) * | 1987-02-26 | 1988-05-24 | Alza Corporation | Skin permeation enhancer compositions using glycerol monolaurate |
DE3710216A1 (de) * | 1987-03-27 | 1988-10-06 | Rentschler Arzneimittel | Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen |
JPH0720866B2 (ja) * | 1987-05-15 | 1995-03-08 | 三生製薬株式会社 | エペリゾン又はトルペリゾン或いはそれらの塩類含有経皮適用製剤 |
US5223261A (en) * | 1988-02-26 | 1993-06-29 | Riker Laboratories, Inc. | Transdermal estradiol delivery system |
CH679119A5 (hu) * | 1988-05-13 | 1991-12-31 | Sandoz Ag | |
GB2230444B (en) * | 1989-04-19 | 1993-12-08 | Ritchie Swanson John | Therapeutic compositions. |
US5219877A (en) * | 1989-09-25 | 1993-06-15 | Bristol-Myers Squibb Company | Lauryl alcohol as skin penetration enhancer for topical imidazole agents |
US5397771A (en) * | 1990-05-10 | 1995-03-14 | Bechgaard International Research And Development A/S | Pharmaceutical preparation |
WO1991016929A1 (en) * | 1990-05-10 | 1991-11-14 | Novo Nordisk A/S | A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols |
IL98747A0 (en) * | 1991-07-05 | 1992-07-15 | Yissum Res Dev Co | Ophthalmic compositions |
US5681852A (en) * | 1993-11-12 | 1997-10-28 | The Procter & Gamble Company | Desquamation compositions |
ES2171522T3 (es) * | 1993-11-12 | 2002-09-16 | Procter & Gamble | Composiciones de desescamacion que contienen acido salicilico y compuestos bipolares. |
US5821237A (en) * | 1995-06-07 | 1998-10-13 | The Procter & Gamble Company | Compositions for visually improving skin |
US6005135A (en) * | 1996-03-21 | 1999-12-21 | Exxon Chemical Patents Inc. | Water-borne polymeric vehicle for coating compositions containing an amine or ammonium salt of phenolic ester alcohols |
US6096326A (en) * | 1997-08-15 | 2000-08-01 | Scandinavian-American Import/Export Corporation | Skin care compositions and use |
US7258869B1 (en) | 1999-02-08 | 2007-08-21 | Alza Corporation | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle |
WO2000045790A2 (en) † | 1999-02-08 | 2000-08-10 | Alza Corporation | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles |
US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
AU2007266475B2 (en) | 2006-05-30 | 2009-12-03 | Intarcia Therapeutics, Inc. | Two-piece, internal-channel osmotic delivery system flow modulator |
NZ574524A (en) | 2006-08-09 | 2011-07-29 | Intarcia Therapeutics Inc | Piston assembly for positioning lumen of a reservoir for an osmotic delivery having a columnar body and a spring |
AU2008244523B2 (en) | 2007-04-23 | 2012-02-16 | Intarcia Therapeutics, Inc. | Suspension formulations of insulinotropic peptides and uses thereof |
US8623387B2 (en) | 2007-11-22 | 2014-01-07 | Medrx Co., Ltd. | External preparation composition comprising fatty acid-based ionic liquid as active ingredient |
CA2726861C (en) | 2008-02-13 | 2014-05-27 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents |
WO2011037623A1 (en) | 2009-09-28 | 2011-03-31 | Intarcia Therapeutics, Inc. | Rapid establishment and/or termination of substantial steady-state drug delivery |
JP2012020991A (ja) | 2010-06-16 | 2012-02-02 | Takasago Internatl Corp | 経皮吸収促進剤、及びこれを含有する皮膚外用製剤 |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
JP5820207B2 (ja) * | 2011-09-13 | 2015-11-24 | 日東電工株式会社 | 経皮吸収促進用組成物および貼付製剤 |
JP5820206B2 (ja) | 2011-09-13 | 2015-11-24 | 日東電工株式会社 | 経皮吸収促進用組成物および貼付製剤 |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
JP6482570B2 (ja) | 2014-10-30 | 2019-03-13 | 旭化成株式会社 | 経皮吸収促進剤及び経皮吸収促進助剤 |
EP3302354B1 (en) | 2015-06-03 | 2023-10-04 | i2o Therapeutics, Inc. | Implant placement systems |
AU2017268161B2 (en) | 2016-05-16 | 2020-03-12 | Intarcia Therapeutics, Inc. | Glucagon-receptor selective polypeptides and methods of use thereof |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
CA3049034A1 (en) | 2017-01-03 | 2018-07-12 | Intarcia Therapeutics, Inc. | Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug |
-
1975
- 1975-06-26 DE DE19752528516 patent/DE2528516A1/de active Pending
- 1975-06-27 SE SE7507414A patent/SE7507414L/xx unknown
- 1975-07-01 NL NL7507798A patent/NL7507798A/xx unknown
- 1975-07-02 YU YU01704/75A patent/YU170475A/xx unknown
- 1975-07-03 HU HUSA2816A patent/HU170215B/hu unknown
- 1975-07-03 ES ES439113A patent/ES439113A1/es not_active Expired
- 1975-07-03 IL IL47634A patent/IL47634A/xx unknown
- 1975-07-03 NZ NZ178011A patent/NZ178011A/xx unknown
- 1975-07-03 FR FR7520946A patent/FR2276832A1/fr active Granted
- 1975-07-04 BE BE158022A patent/BE831042A/xx unknown
- 1975-07-04 JP JP50082022A patent/JPS5132724A/ja active Pending
- 1975-07-04 ZA ZA754304A patent/ZA754304B/xx unknown
- 1975-07-04 GB GB28246/75A patent/GB1518683A/en not_active Expired
- 1975-07-07 AU AU82801/75A patent/AU8280175A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
ZA754304B (en) | 1977-02-23 |
FR2276832A1 (fr) | 1976-01-30 |
ES439113A1 (es) | 1977-10-16 |
NZ178011A (en) | 1978-07-28 |
AU8280175A (en) | 1977-01-13 |
DE2528516A1 (de) | 1976-01-22 |
NL7507798A (nl) | 1976-01-07 |
GB1518683A (en) | 1978-07-19 |
IL47634A (en) | 1978-07-31 |
YU170475A (en) | 1984-02-29 |
IL47634A0 (en) | 1975-10-15 |
HU170215B (hu) | 1977-04-28 |
FR2276832B1 (hu) | 1978-10-06 |
SE7507414L (sv) | 1976-01-07 |
JPS5132724A (hu) | 1976-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE831042A (fr) | Compositions pharmaceutiques a resorption per-cutanee contenant des alcools aliphatiques superieurs et des agents tensio-actifs | |
AT347588B (de) | Arzneimittelwirkstofftraeger | |
FR2430410B1 (fr) | Phenethanolamines et compositions pharmaceutiques en contenant | |
FR2273555A1 (fr) | Agent d'administration intravasculaire | |
BE851590A (fr) | Compositions pharmaceutiques renfermant des pyrethrinoides | |
BE759041A (fr) | Compositions photopolymerisables contenant des aminophenylcetones et des adjuvants | |
FR2280632A1 (fr) | Dihydroxysulfonates contenant des structures ether | |
FR2295739A1 (fr) | Oxo-20 homopregnanes et medicaments qui en contiennent | |
IT1050272B (it) | Agenti deodoranti microbicidi e preparati che li contengono | |
BE849788A (fr) | Ethers d'imidazolyl-oximes et medicaments qui en contiennent | |
FR2315939A1 (fr) | Complexes actifs du point de vue pharmaceutique et compositions pharmaceutiques les contenant | |
BE862433A (fr) | Compositions medicamenteuses contenant des sterolines et leurs applications therapeutiques | |
FR2273523A1 (fr) | Nouvelles compositions pharmaceutiques contenant des composes aromatiques | |
CH524998A (it) | Procedimento per l'esecuzione di un modello dentario e mascellare | |
FR2279333A1 (fr) | Agent d'inhibition des fongi du sol | |
BE836559A (fr) | Compositions desinfectantes d'oxydiacetaldehyde | |
FR2277577A1 (fr) | Derives de l'acide prostanoique et medicaments qui en renferment | |
BE776120A (fr) | Nouvelles preparations pharmaceutiques contenant un peptide | |
FR2281766A1 (fr) | Oestratetraenes et medicament contenant ces substances | |
FR2314724A1 (fr) | Medicament anticonvulsif contenant un diphenylsilane | |
BE849383A (fr) | Compositions pharmaceutiques a proprietes anticonvulsives contenant des phenylsilanes | |
BE764258A (fr) | Acides 2- (phenylsubstitue)- propioniques et compositions en contenant | |
BE829889A (fr) | Distributeur d'essuie-mains | |
BE786128A (fr) | Compositions effervescentes contenant l'ester methylique de l-aspartyl-l-3-phenylalanine | |
SE7510045L (sv) | Anthelmintisk aktiva basiskt substituerade 2-karbalkoxiamino-bensimidazolyl-5(6)-fenyletrar och- ketoner samt forfarande for deras framstellning |